Advisory Committees; Tentative Schedule of Meetings for 2009, 1690-1692 [E9-451]
Download as PDF
<![CDATA[
1690
Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
Contact Person for More Information:
Theodore Katz, Executive Secretary, NIOSH,
CDC, 1600 Clifton Road, Mailstop E–20,
Atlanta, Georgia 30333, Telephone (513)
533–6800, Toll Free 1 (800) CDC–INFO, email ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: January 7, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–524 Filed 1–12–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Child Care Quarterly Case
Record Report—ACF–801.
OMB No.: 0970–0167.
Description: Section 658K of the Child
Care and Development Block Grant Act
of 1990 (Pub. L. 101–508, 42 U.S.C.
9858) requires that States and
Territories submit monthly case-level
data on the children and families
receiving direct services under the Child
Care and Development Fund. The
implementing regulations for the
statutorily required reporting are at 45
CFR 98.70. Case-level reports, submitted
quarterly or monthly (at grantee option),
include monthly sample or full
population case-level data. The data
elements to be included in these reports
are represented in the ACF–801. ACF
uses disaggregate data to determine
program and participant characteristics
as well as costs and levels of child care
services provided. This provides ACF
with the information necessary to make
reports to Congress, address national
child care needs, offer technical
assistance to grantees, meet performance
measures, and conduct research.
Consistent with the statute and
regulations, ACF requests extension of
the ACF–801. With this extension, ACF
is proposing several changes and
clarifications to the reporting
requirements and instructions.
Respondents: States, the District of
Columbia, and Territories including
Puerto Rico, Guam, the Virgin Islands,
American Samoa, and the Northern
Mariana Islands.
ANNUAL BURDEN ESTIMATES
Number
of respondents
Instrument
ACF–801 ..........................................................................................................................................
Estimated Total Annual Burden
Hours: 4,480
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Fax: 202–395–6974,
Attn: Desk Officer for the
Administration for Children and
Families.
VerDate Nov<24>2008
19:10 Jan 12, 2009
Jkt 217001
Dated: January 8, 2009.
Janean Chambers,
Reports Clearance Officer.
[FR Doc. E9–447 Filed 1–12–09; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0038]
Advisory Committees; Tentative
Schedule of Meetings for 2009
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
tentative schedule of forthcoming
meetings of its public advisory
committees for 2009. During 1991, at the
request of the Commissioner of Food
and Drugs (the Commissioner), the
Institute of Medicine (the IOM)
conducted a study of the use of FDA’s
advisory committees. In its final report,
one of the IOM’s recommendations was
for the agency to publish an annual
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Number
of responses
per respondent
Average
burden
hours per
response
Total burden hours
4
20
4,480
56
tentative schedule of its meetings in the
Federal Register. This publication
implements the IOM’s recommendation.
FOR FURTHER INFORMATION CONTACT:
Theresa L. Green, Advisory Committee
Oversight and Management Staff (HF–
4), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857,
301–827–1220.
SUPPLEMENTARY INFORMATION: The IOM,
at the request of the Commissioner,
undertook a study of the use of the
FDA’s advisory committees. In its final
report in 1992, one of the IOM’s
recommendations was for FDA to adopt
a policy of publishing an advance yearly
schedule of its upcoming public
advisory committee meetings in the
Federal Register; FDA has implemented
this recommendation. The annual
publication of tentatively scheduled
advisory committee meetings will
provide both advisory committee
members and the public with the
opportunity, in advance, to schedule
attendance at FDA’s upcoming advisory
committee meetings. Because the
schedule is tentative, amendments to
this notice will not be published in the
Federal Register. However, changes to
the schedule will be posted on the FDA
E:\FR\FM\13JAN1.SGM
13JAN1
Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices
advisory committees’ Internet site
located at https://www.fda.gov/oc/
advisory/default.htm. FDA will
continue to publish a Federal Register
notice 15 days in advance of each
upcoming advisory committee meeting,
to announce the meeting (21 CFR 14.20).
The following list announces FDA’s
tentatively scheduled advisory
committee meetings for 2009. You may
Committee Name
1691
also obtain up-to-date information by
calling the Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area).
Advisory Committee
10-Digit Information
Line Code
Tentative Date of Meeting(s)
OFFICE OF THE COMMISSIONER
Pediatric Advisory Committee
March 23–24, June 22–23, September 21–22, December
7–8
8732310001
Risk Communication Advisory Committee
February 26–27, April 30–May 1, August 13–14, November 12–13
8732112560
Science Board to the Food and Drug Administration
February 24, May 18, August 17, November 16
3014512603
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Allergenic Products Advisory Committee
March 5, October 22
3014512388
Blood Products Advisory Committee
January 9, April 1, July 20–21, November 16–17
3014519516
Cellular, Tissue and Gene Therapies Advisory Committee
May 14–15, November 5–6
3014512389
Transmissible Spongiform Encephalopathies Advisory
Committee
To be announced
3014512392
Vaccines and Related Biological Products Advisory Committee
February 18–19, May 20–21, September 23–24, November 18–19
3014512391
CENTER FOR DRUG EVALUATION AND RESEARCH
Anesthetic and Life Support Drugs Advisory Committee
January 29–30, April dates to be announced
3014512529
Anti-Infective Drugs Advisory Committee
To be announced
3014512530
Antiviral Drugs Advisory Committee
To be announced
3014512531
Arthritis Advisory Committee
March 5, June 16–17, October 27–28
3014512532
Cardiovascular and Renal Drugs Advisory Committee
February 3, March 18–19, July 28–29, December 7–8
3014512533
Dermatologic and Ophthalmic Drugs Advisory Committee
To be announced
3014512534
Drug Safety and Risk Management Advisory Committee
January 30, April dates to be announced
3014512535
Endocrinologic and Metabolic Drugs Advisory Committee
April 2–3
3014512536
Gastrointestinal Drugs Advisory Committee
February 17
3014512538
Nonprescription Drugs Advisory Committee
April dates to be announced
3014512541
Oncologic Drugs Advisory Committee
February 25, March 24–25, May dates to be announced,
July 14–15, September 15–16, December 16–17
3014512542
Peripheral and Central Nervous System Drugs Advisory
Committee
January 7–8
3014512543
Pharmaceutical Science and Clinical Pharmacology, Advisory Committee for
March dates to be announced
3014512539
Psychopharmacologic Drugs Advisory Committee
March 26
3014512544
Pulmonary-Allergy Drugs Advisory Committee
February 4
3014512545
Reproductive Health Drugs, Advisory Committee for
May and August dates to be announced
3014512537
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
Device Good Manufacturing Practice Advisory Committee
April 15, October 5–6
3014512398
Medical Devices Advisory Committee (Comprised of 18 Panels)
VerDate Nov<24>2008
19:10 Jan 12, 2009
Jkt 217001
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
E:\FR\FM\13JAN1.SGM
13JAN1
1692
Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices
Committee Name
Advisory Committee
10-Digit Information
Line Code
Tentative Date of Meeting(s)
Anesthesiology and Respiratory Therapy Devices Panel
February 5, April 30, July 23, September 17, November 12
3014512624
Circulatory System Devices Panel
February 25, May 27, September 24
3014512625
Clinical Chemistry and Clinical Toxicology Devices Panel
March 18–19, June 17–18, October 21–22
3014512514
Dental Products Panel
February 11, May 6, June 17, September 16, December 9
3014512518
Ear, Nose, and Throat Devices Panel
February 24, May 19, August 18, November 17
3014512522
Gastroenterology-Urology Devices Panel
March 20, October 15
3014512523
General and Plastic Surgery Devices Panel
February 26–27, June 9–10, October 15–16
3014512519
General Hospital and Personal Use Devices Panel
March 25–26, July 29–30, October 21–22
3014512520
Hematology and Pathology Devices Panel
April 24, July 17, October 23
3014512515
Immunology Devices Panel
October 15–16
3014512516
Medical Devices Dispute Resolution Panel
Meetings occur as needed
3014510232
Microbiology Devices Panel
February 24–25, September 22–23, October 27–28
3014512517
Molecular and Clinical Genetics Panel
April 15, October 5–6
3014510231
Neurological Devices Panel
February 26–27, May 14–15, September 17–18, December 2–3
3014512513
Obstetrics and Gynecology Devices Panel
February 5–6, May 14–15, August 13–14, November 12–
13
3014512524
Ophthalmic Devices Panel
February 12–13, May 14–15, September 24–25,November
19–20
3014512396
Orthopaedic and Rehabilitation Devices Panel
February 3–4, April 14–15, June 9–10, August 11–12, October 15–16, December 1–2
3014512521
Radiological Devices Panel
February 18, May 12, August 4, November 17
3014512526
National Mammography Quality Assurance Advisory Committee
November 4–5
3014512397
Technical Electronic Product Radiation Safety Standards
Committee
No meeting tentatively scheduled for 2009
3014512399
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory Committee
May 20–21
3014510564
CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory Committee
April 14
3014512548
NATIONAL CENTER FOR TOXILOGICAL RESEARCH (NCTR)
Science Advisory Board to NCTR
November 17–18
3014512559
Dated: December 24, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E9–451 Filed 1–12–09; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4160–01–S
[Docket No. FDA–2009–D–0675]
Food and Drug Administration
Draft Guidance for Industry on Good
Importer Practices; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
VerDate Nov<24>2008
19:10 Jan 12, 2009
Jkt 217001
PO 00000
Notice.
Frm 00031
Fmt 4703
Sfmt 4703
SUMMARY: The Food and Drug
Administration (FDA) is announcing on
behalf of several members of the
Interagency Working Group on Import
Safety (agencies) the availability of a
draft guidance for industry entitled
‘‘Good Importer Practices.’’ This draft
guidance document provides general
recommendations to importers on
possible practices and procedures they
may follow to increase the likelihood
the products they import are in
E:\FR\FM\13JAN1.SGM
13JAN1
]]>Agencies
[Federal Register Volume 74, Number 8 (Tuesday, January 13, 2009)]
[Notices]
[Pages 1690-1692]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-451]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2008-N-0038]
Advisory Committees; Tentative Schedule of Meetings for 2009
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing a
tentative schedule of forthcoming meetings of its public advisory
committees for 2009. During 1991, at the request of the Commissioner of
Food and Drugs (the Commissioner), the Institute of Medicine (the IOM)
conducted a study of the use of FDA's advisory committees. In its final
report, one of the IOM's recommendations was for the agency to publish
an annual tentative schedule of its meetings in the Federal Register.
This publication implements the IOM's recommendation.
FOR FURTHER INFORMATION CONTACT: Theresa L. Green, Advisory Committee
Oversight and Management Staff (HF-4), Food and Drug Administration,
5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.
SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner,
undertook a study of the use of the FDA's advisory committees. In its
final report in 1992, one of the IOM's recommendations was for FDA to
adopt a policy of publishing an advance yearly schedule of its upcoming
public advisory committee meetings in the Federal Register; FDA has
implemented this recommendation. The annual publication of tentatively
scheduled advisory committee meetings will provide both advisory
committee members and the public with the opportunity, in advance, to
schedule attendance at FDA's upcoming advisory committee meetings.
Because the schedule is tentative, amendments to this notice will not
be published in the Federal Register. However, changes to the schedule
will be posted on the FDA
[[Page 1691]]
advisory committees' Internet site located at https://www.fda.gov/oc/
advisory/default.htm. FDA will continue to publish a Federal Register
notice 15 days in advance of each upcoming advisory committee meeting,
to announce the meeting (21 CFR 14.20).
The following list announces FDA's tentatively scheduled advisory
committee meetings for 2009. You may also obtain up-to-date information
by calling the Advisory Committee Information Line, 1-800-741-8138
(301-443-0572 in the Washington, DC area).
------------------------------------------------------------------------
Advisory Committee
Committee Name Tentative Date of 10-Digit Information
Meeting(s) Line Code
------------------------------------------------------------------------
OFFICE OF THE COMMISSIONER
------------------------------------------------------------------------
Pediatric Advisory March 23-24, June 22-23, 8732310001
Committee September 21-22,
December 7-8
------------------------------------------------------------------------
Risk Communication February 26-27, April 30- 8732112560
Advisory Committee May 1, August 13-14,
November 12-13
------------------------------------------------------------------------
Science Board to the February 24, May 18, 3014512603
Food and Drug August 17, November 16
Administration
------------------------------------------------------------------------
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
------------------------------------------------------------------------
Allergenic Products March 5, October 22 3014512388
Advisory Committee
------------------------------------------------------------------------
Blood Products Advisory January 9, April 1, July 3014519516
Committee 20-21, November 16-17
------------------------------------------------------------------------
Cellular, Tissue and May 14-15, November 5-6 3014512389
Gene Therapies Advisory
Committee
------------------------------------------------------------------------
Transmissible Spongiform To be announced 3014512392
Encephalopathies
Advisory Committee
------------------------------------------------------------------------
Vaccines and Related February 18-19, May 20- 3014512391
Biological Products 21, September 23-24,
Advisory Committee November 18-19
------------------------------------------------------------------------
CENTER FOR DRUG EVALUATION AND RESEARCH
------------------------------------------------------------------------
Anesthetic and Life January 29-30, April 3014512529
Support Drugs Advisory dates to be announced
Committee
------------------------------------------------------------------------
Anti-Infective Drugs To be announced 3014512530
Advisory Committee
------------------------------------------------------------------------
Antiviral Drugs Advisory To be announced 3014512531
Committee
------------------------------------------------------------------------
Arthritis Advisory March 5, June 16-17, 3014512532
Committee October 27-28
------------------------------------------------------------------------
Cardiovascular and Renal February 3, March 18-19, 3014512533
Drugs Advisory July 28-29, December 7-
Committee 8
------------------------------------------------------------------------
Dermatologic and To be announced 3014512534
Ophthalmic Drugs
Advisory Committee
------------------------------------------------------------------------
Drug Safety and Risk January 30, April dates 3014512535
Management Advisory to be announced
Committee
------------------------------------------------------------------------
Endocrinologic and April 2-3 3014512536
Metabolic Drugs
Advisory Committee
------------------------------------------------------------------------
Gastrointestinal Drugs February 17 3014512538
Advisory Committee
------------------------------------------------------------------------
Nonprescription Drugs April dates to be 3014512541
Advisory Committee announced
------------------------------------------------------------------------
Oncologic Drugs Advisory February 25, March 24- 3014512542
Committee 25, May dates to be
announced, July 14-15,
September 15-16,
December 16-17
------------------------------------------------------------------------
Peripheral and Central January 7-8 3014512543
Nervous System Drugs
Advisory Committee
------------------------------------------------------------------------
Pharmaceutical Science March dates to be 3014512539
and Clinical announced
Pharmacology, Advisory
Committee for
------------------------------------------------------------------------
Psychopharmacologic March 26 3014512544
Drugs Advisory
Committee
------------------------------------------------------------------------
Pulmonary-Allergy Drugs February 4 3014512545
Advisory Committee
------------------------------------------------------------------------
Reproductive Health May and August dates to 3014512537
Drugs, Advisory be announced
Committee for
------------------------------------------------------------------------
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
------------------------------------------------------------------------
Device Good April 15, October 5-6 3014512398
Manufacturing Practice
Advisory Committee
------------------------------------------------------------------------
Medical Devices Advisory Committee (Comprised of 18 Panels)
------------------------------------------------------------------------
[[Page 1692]]
Anesthesiology and February 5, April 30, 3014512624
Respiratory Therapy July 23, September 17,
Devices Panel November 12
------------------------------------------------------------------------
Circulatory System February 25, May 27, 3014512625
Devices Panel September 24
------------------------------------------------------------------------
Clinical Chemistry and March 18-19, June 17-18, 3014512514
Clinical Toxicology October 21-22
Devices Panel
------------------------------------------------------------------------
Dental Products Panel February 11, May 6, June 3014512518
17, September 16,
December 9
------------------------------------------------------------------------
Ear, Nose, and Throat February 24, May 19, 3014512522
Devices Panel August 18, November 17
------------------------------------------------------------------------
Gastroenterology-Urology March 20, October 15 3014512523
Devices Panel
------------------------------------------------------------------------
General and Plastic February 26-27, June 9- 3014512519
Surgery Devices Panel 10, October 15-16
------------------------------------------------------------------------
General Hospital and March 25-26, July 29-30, 3014512520
Personal Use Devices October 21-22
Panel
------------------------------------------------------------------------
Hematology and Pathology April 24, July 17, 3014512515
Devices Panel October 23
------------------------------------------------------------------------
Immunology Devices Panel October 15-16 3014512516
------------------------------------------------------------------------
Medical Devices Dispute Meetings occur as needed 3014510232
Resolution Panel
------------------------------------------------------------------------
Microbiology Devices February 24-25, 3014512517
Panel September 22-23,
October 27-28
------------------------------------------------------------------------
Molecular and Clinical April 15, October 5-6 3014510231
Genetics Panel
------------------------------------------------------------------------
Neurological Devices February 26-27, May 14- 3014512513
Panel 15, September 17-18,
December 2-3
------------------------------------------------------------------------
Obstetrics and February 5-6, May 14-15, 3014512524
Gynecology Devices August 13-14, November
Panel 12-13
------------------------------------------------------------------------
Ophthalmic Devices Panel February 12-13, May 14- 3014512396
15, September 24-
25,November 19-20
------------------------------------------------------------------------
Orthopaedic and February 3-4, April 14- 3014512521
Rehabilitation Devices 15, June 9-10, August
Panel 11-12, October 15-16,
December 1-2
------------------------------------------------------------------------
Radiological Devices February 18, May 12, 3014512526
Panel August 4, November 17
------------------------------------------------------------------------
National Mammography November 4-5 3014512397
Quality Assurance
Advisory Committee
------------------------------------------------------------------------
Technical Electronic No meeting tentatively 3014512399
Product Radiation scheduled for 2009
Safety Standards
Committee
------------------------------------------------------------------------
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
------------------------------------------------------------------------
Food Advisory Committee May 20-21 3014510564
------------------------------------------------------------------------
CENTER FOR VETERINARY MEDICINE
------------------------------------------------------------------------
Veterinary Medicine April 14 3014512548
Advisory Committee
------------------------------------------------------------------------
NATIONAL CENTER FOR TOXILOGICAL RESEARCH (NCTR)
------------------------------------------------------------------------
Science Advisory Board November 17-18 3014512559
to NCTR
------------------------------------------------------------------------
Dated: December 24, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E9-451 Filed 1-12-09; 8:45 am]
BILLING CODE 4160-01-S
